Edition:
United Kingdom

Foamix Pharmaceuticals Ltd (FOMX.OQ)

FOMX.OQ on NASDAQ Stock Exchange Global Market

5.14USD
19 Oct 2018
Change (% chg)

$-0.18 (-3.38%)
Prev Close
$5.32
Open
$5.34
Day's High
$5.49
Day's Low
$5.12
Volume
70,815
Avg. Vol
125,865
52-wk High
$7.55
52-wk Low
$4.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.96 -0.465
Mar '18 0.91 -0.692
FY 2017 Dec '17 1.04 -0.463
Sep '17 0.90 -0.470
Jun '17 0.80 -0.438
Mar '17 0.93 -0.387
FY 2016 Dec '16 1.49 -0.292
Sep '16 2.54 -0.189
Jun '16 0.75 -0.267
Mar '16 0.75 -0.147
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 1.21 1.33 1.00 1.90
Quarter Ending Mar-19 2 1.46 1.50 1.42 --
Year Ending Dec-18 4 4.37 5.00 3.90 7.65
Year Ending Dec-19 4 10.50 25.00 4.00 28.29
Earnings (per share)
Quarter Ending Dec-18 4 -0.41 -0.17 -0.94 -0.40
Quarter Ending Mar-19 2 -0.22 -0.20 -0.24 --
Year Ending Dec-18 5 -1.82 -1.60 -2.32 -1.52
Year Ending Dec-19 5 -1.45 -0.87 -2.40 -1.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta -- 0.93 0.88
Price to Sales (TTM) 41.95 124.37 5.83
Price to Book (MRQ) 2.39 15.29 4.89
Price to Tangible Book (MRQ) 2.39 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 58.20 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 6.12 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago 221.69 103.65 5.80
Sales - 5 Yr. Growth Rate -- 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -63.89 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago -86.23 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 9.03 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.93 12.76
Total Debt to Equity (MRQ) 0.00 36.74 17.18
Interest Coverage (TTM) -- -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 99.72 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -833.38 -- --
EBITD - 5 Yr. Avg -- -579.09 11.01
Operating Margin (TTM) -836.30 -786.66 4.07
Operating Margin - 5 Yr. Avg. -- -600.20 6.34
Pre-Tax Margin (TTM) -817.45 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -- -605.79 6.78
Net Profit Margin (TTM) -823.74 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -- -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 84,632 22,677,535 808,218,600
Net Income/Employee (TTM) -697,147 1,703,754 95,058,584
Receivable Turnover (TTM) 7.42 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.06 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -46.20 -1.39 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -49.58 0.21 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -49.79 1.17 15.99
Return on Equity - 5 Yr. Avg. -- 2.74 16.87
  1 Year 3 Year 5 Year
Sales % 551.00 57.90 --
EPS (TTM) % -55.40 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Foamix Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.44%
# of Holders: 68
Total Shares Held: 25,957,618
3 Mo. Net Change: 2,223,095
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 8
# Reduced Positions: 1
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.